BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 32277807)

  • 21. The prognosis of colorectal cancer liver metastases associated with inflammatory bowel disease: An exploratory analysis.
    Margonis GA; Buettner S; Andreatos N; Wagner D; Sasaki K; Galjart B; Kamphues C; Pawlik TM; Poultsides G; Kaczirek K; Lønning PE; Verhoef C; Kreis ME; Wolfgang CL; Weiss MJ
    J Surg Oncol; 2018 Dec; 118(7):1074-1080. PubMed ID: 30261094
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical significance and prognostic relevance of KRAS, BRAF, PI3K and TP53 genetic mutation analysis for resectable and unresectable colorectal liver metastases: A systematic review of the current evidence.
    Tsilimigras DI; Ntanasis-Stathopoulos I; Bagante F; Moris D; Cloyd J; Spartalis E; Pawlik TM
    Surg Oncol; 2018 Jun; 27(2):280-288. PubMed ID: 29937183
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors influencing recurrence following initial hepatectomy for colorectal liver metastases.
    Hallet J; Sa Cunha A; Adam R; Goéré D; Bachellier P; Azoulay D; Ayav A; Grégoire E; Navarro F; Pessaux P;
    Br J Surg; 2016 Sep; 103(10):1366-76. PubMed ID: 27306949
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term outcomes following microwave ablation for liver malignancies.
    Leung U; Kuk D; D'Angelica MI; Kingham TP; Allen PJ; DeMatteo RP; Jarnagin WR; Fong Y
    Br J Surg; 2015 Jan; 102(1):85-91. PubMed ID: 25296639
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemotherapy and targeted therapy for patients with initially unresectable colorectal liver metastases, focusing on conversion hepatectomy and long-term survival.
    Beppu T; Miyamoto Y; Sakamoto Y; Imai K; Nitta H; Hayashi H; Chikamoto A; Watanabe M; Ishiko T; Baba H
    Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S405-13. PubMed ID: 24570379
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcomes after resection and/or radiofrequency ablation for recurrence after treatment of colorectal liver metastases.
    Hof J; Wertenbroek MW; Peeters PM; Widder J; Sieders E; de Jong KP
    Br J Surg; 2016 Jul; 103(8):1055-62. PubMed ID: 27193207
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BRAF mutation is not associated with an increased risk of recurrence in patients undergoing resection of colorectal liver metastases.
    Bachet JB; Moreno-Lopez N; Vigano L; Marchese U; Gelli M; Raoux L; Truant S; Laurent C; Herrero A; Le Roy B; Deguelte Lardiere S; Passot G; Hautefeuille V; De La Fouchardiere C; Artru P; Ameto T; Mabrut JY; Schwarz L; Rousseau B; Lepère C; Coriat R; Brouquet A; Sa Cunha A; Benoist S
    Br J Surg; 2019 Aug; 106(9):1237-1247. PubMed ID: 31183866
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary tumour location affects survival after resection of colorectal liver metastases: A two-institutional cohort study with international validation, systematic meta-analysis and a clinical risk score.
    Gasser E; Braunwarth E; Riedmann M; Cardini B; Fadinger N; Presl J; Klieser E; Ellmerer P; Dupré A; Imai K; Malik H; Baba H; Ulmer H; Schneeberger S; Öfner D; Dinnewitzer A; Stättner S; Primavesi F
    PLoS One; 2019; 14(5):e0217411. PubMed ID: 31150437
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Maximum Diameter and Number of Tumors as a New Prognostic Indicator of Colorectal Liver Metastases.
    Yoshimoto T; Morine Y; Imura S; Ikemoto T; Iwahashi S; Saito YU; Yamada S; Ishikawa D; Teraoku H; Yoshikawa M; Higashijima J; Takasu C; Shimada M
    In Vivo; 2017; 31(3):419-423. PubMed ID: 28438872
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A new prognostic score system of hepatocellular carcinoma following hepatectomy].
    Wang YK; Bi XY; Li ZY; Zhao H; Zhao JJ; Zhou JG; Huang Z; Zhang YF; Li MX; Chen X; Wu XL; Mao R; Hu XH; Hu HJ; Liu JM; Cai JQ
    Zhonghua Zhong Liu Za Zhi; 2017 Dec; 39(12):903-909. PubMed ID: 29262506
    [No Abstract]   [Full Text] [Related]  

  • 31. Discrepancy between recurrence-free survival and overall survival in patients with resectable colorectal liver metastases: a potential surrogate endpoint for time to surgical failure.
    Oba M; Hasegawa K; Matsuyama Y; Shindoh J; Mise Y; Aoki T; Sakamoto Y; Sugawara Y; Makuuchi M; Kokudo N
    Ann Surg Oncol; 2014 Jun; 21(6):1817-24. PubMed ID: 24499828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Postoperative circulating tumour DNA is associated with pathologic response and recurrence-free survival after resection of colorectal cancer liver metastases.
    Bolhuis K; van 't Erve I; Mijnals C; Delis-Van Diemen PM; Huiskens J; Komurcu A; Lopez-Yurda M; van den Broek D; Swijnenburg RJ; Meijer GA; Punt CJA; Fijneman RJA
    EBioMedicine; 2021 Aug; 70():103498. PubMed ID: 34333237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcome after laparoscopic radiofrequency ablation of technically resectable colorectal liver metastases.
    Hammill CW; Billingsley KG; Cassera MA; Wolf RF; Ujiki MB; Hansen PD
    Ann Surg Oncol; 2011 Jul; 18(7):1947-54. PubMed ID: 21399885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical features and prognosis in hepatectomy for colorectal cancer with centrally located liver metastasis.
    Kuo IM; Huang SF; Chiang JM; Yeh CY; Chan KM; Chen JS; Yu MC
    World J Surg Oncol; 2015 Mar; 13():92. PubMed ID: 25889950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of BRAF Mutations With Survival and Recurrence in Surgically Treated Patients With Metastatic Colorectal Liver Cancer.
    Margonis GA; Buettner S; Andreatos N; Kim Y; Wagner D; Sasaki K; Beer A; Schwarz C; Løes IM; Smolle M; Kamphues C; He J; Pawlik TM; Kaczirek K; Poultsides G; Lønning PE; Cameron JL; Burkhart RA; Gerger A; Aucejo FN; Kreis ME; Wolfgang CL; Weiss MJ
    JAMA Surg; 2018 Jul; 153(7):e180996. PubMed ID: 29799910
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictive factors for time to recurrence, treatment and post-recurrence survival in patients with initially resected colorectal liver metastases.
    Angelsen JH; Viste A; Løes IM; Eide GE; Hoem D; Sorbye H; Horn A
    World J Surg Oncol; 2015 Dec; 13():328. PubMed ID: 26631156
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Diagnosis and treatment of colorectal liver metastases - workflow].
    Grundmann RT; Hermanek P; Merkel S; Germer CT; Grundmann RT; Hauss J; Henne-Bruns D; Herfarth K; Hermanek P; Hopt UT; Junginger T; Klar E; Klempnauer J; Knapp WH; Kraus M; Lang H; Link KH; Löhe F; Merkel S; Oldhafer KJ; Raab HR; Rau HG; Reinacher-Schick A; Ricke J; Roder J; Schäfer AO; Schlitt HJ; Schön MR; Stippel D; Tannapfel A; Tatsch K; Vogl TJ;
    Zentralbl Chir; 2008 Jun; 133(3):267-84. PubMed ID: 18563694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Prognostic Value of Total Tumor Volume Response Compared With RECIST1.1 in Patients With Initially Unresectable Colorectal Liver Metastases Undergoing Systemic Treatment.
    Wesdorp NJ; Bolhuis K; Roor J; van Waesberghe JTM; van Dieren S; van Amerongen MJ; Chapelle T; Dejong CHC; Engelbrecht MRW; Gerhards MF; Grunhagen D; van Gulik TM; Hermans JJ; de Jong KP; Klaase JM; Liem MSL; van Lienden KP; Molenaar IQ; Patijn GA; Rijken AM; Ruers TM; Verhoef C; de Wilt JHW; Swijnenburg RJ; Punt CJA; Huiskens J; Kazemier G
    Ann Surg Open; 2021 Dec; 2(4):e103. PubMed ID: 37637880
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of primary tumour and patient factors on survival in patients undergoing curative resection and treatment for liver metastases from colorectal cancer.
    Scherman P; Syk I; Holmberg E; Naredi P; Rizell M
    BJS Open; 2020 Feb; 4(1):118-132. PubMed ID: 32011815
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Meta-analysis of the association between primary tumour location and prognosis after surgical resection of colorectal liver metastases.
    Wang XY; Zhang R; Wang Z; Geng Y; Lin J; Ma K; Zuo JL; Lu L; Zhang JB; Zhu WW; Chen JH
    Br J Surg; 2019 Dec; 106(13):1747-1760. PubMed ID: 31386192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.